SCHEMBL455193

SCHEMBL455193

CC=CCNCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL866509 1.00
SCHEMBL232854 1.00
Hydrochloric Acid SCHEMBL712887 0.98 PPARG (0.36)
SCHEMBL9480599 0.85 SOAT1 (0.38)
SCHEMBL9480609 0.85 SOAT1 (0.38)
SCHEMBL29957177 0.84 S1PR1 (0.38)
SCHEMBL865038 0.82 GRIK1 (0.50)
SCHEMBL866402 0.82 GRIK1 (0.50)
SCHEMBL11694674 0.79
SCHEMBL526332 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230391828-A1 REGULATORS OF CELL DIVISION TECHNISCHE UNIVERSITAT DRESDEN (DE) 2023-12-07 US claimed
EP-4225780-A2 REGULATORS OF CELL DIVISION Technische Universität Dresden (DE) 2023-08-16 EP claimed
WO-2022074072-A2 REGULATORS OF CELL DIVISION Technische Universität Dresden (DE) 2022-04-14 WO claimed
EP-3981784-A1 REGULATORS OF CELL DIVISION Technische Universität Dresden (DE) 2022-04-13 EP claimed
CN-112585116-A Synthesis of (2S, 3R, 4R) -4, 5-dihydroxyisoleucine and derivatives thereof 海德堡医药研究有限责任公司 2021-03-30 CN claimed
WO-2018031531-A1 ENGINEERED BACTERIA FOR NON-INVASIVE IMAGING AND THERAPEUTIC APPLICATIONS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2018-02-15 WO claimed
US-20150148524-A1 AMINO ACID ANALOGUES AND METHODS FOR THEIR SYNTHESIS UNIV MONASH (AU) 2015-05-28 US claimed
EP-2870128-A1 AMINO ACID ANALOGUES AND METHODS FOR THEIR SYNTHESIS Monash University (AU) 2015-05-13 EP claimed
US-20140255991-A1 OVEREXPRESSION OF AMINOACYL-tRNA SYNTHETASES FOR EFFICIENT PRODUCTION OF ENGINEERED PROTEINS CONTAINING AMINO ACID ANALOGUES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2014-09-11 US claimed
US-8748570-B2 Insulin analogues SYNGENE LIMITED (AU) 2014-06-10 US claimed
WO-2011146973-A1 INSULIN ANALOGUES MONASH UNIVERSITY (AU) 2011-12-01 WO claimed
WO-2011146972-A1 METHODS FOR THE SYNTHESIS OF DICARBA BRIDGES IN PEPTIDES MONASH UNIVERSITY (AU) 2011-12-01 WO claimed
US-7723070-B2 Adding an desired amino acid analog to a medium containing a host cell with a vector coding for aminoacyl-tRNA synthetase and a vector coding for the polypeptide of interest; and growing the cell to produce the modified polypeptide CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2010-05-25 US claimed
US-20080160609-A1 Dihydrofolate reductase; site directed mutagenesis; point mutations; auxotroph host cells CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2008-07-03 US claimed
US-20070178554-A1 Orthogonal Aminoacyl Synthetase-tRNA Pairs for Incorporating Unnatural Amino Acids Into Proteins NEURION PHARMACEUTICALS, INC. 2007-08-02 US claimed
US-7198915-B2 Preparing modified/artificial polypeptides; mimetics CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2007-04-03 US claimed
US-20060014159-A1 Methods of determining precise HERG interactions and designing compounds based on said interactions NEURION PHARMACEUTICALS, INC. (US) 2006-01-19 US claimed
US-20040058415-A1 Preparing modified/artificial polypeptides; mimetics CALIFORNIA INSTITUTE OF TECHNOLOGY 2004-03-25 US claimed
US-6586207-B2 Host cell is a methionine auxotroph; methionine-tRNA synthetase overexpressed in presence of analogues and absence of methionine; protein is modified dihydrofolate reductase CALIFORNIA INSTITUTE OF TECHNOLOGY 2003-07-01 US claimed
US-20020042097-A1 Host cell is a methionine auxotroph; methionine-tRNA synthetase overexpressed in presence of analogues and absence of methionine; protein is modified dihydrofolate reductase CALIFORNIA INSTITUTE OF TECHNOLOGY 2002-04-11 US claimed